Search Within

Yildirim Dogan

Formats
  1. Meeting Abstract (8)
  2. Journal Article (7)
Groups
  1. Sloan Kettering Institute Postdocs (15)
  2. Sloan Kettering Institute Faculty (14)
  3. Center for Hematologic Malignancies (9)
  4. GSK Faculty (9)
  5. Human Oncology and Pathogenesis Program (9)
  6. Bone Marrow Transplant (8)

More Groups

People
  1. Alan Hanash (8)
  2. Amanda Holland (8)
  3. Arnab Ghosh (8)
  4. Michel Sadelain (8)
  5. Robert Jenq (8)
  6. Lauren Young (7)

More People

Years
  1. 2021 (1)
  2. 2014 (2)
  3. 2013 (3)
  4. 2012 (3)
  5. 2011 (3)
  6. 2010 (3)
Publications
  1. Biology of Blood and Marrow Transplantation (3)
  2. Blood (2)
  3. Cancer Research (2)
  4. Molecular Cancer Therapeutics (2)
  5. Cell Stem Cell (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. American Association for Cancer Research (5)
  2. Elsevier Inc. (3)
  3. American Society of Hematology (2)
  4. American Society for Clinical Investigation (1)
  5. Cell Press (1)
  6. Ferrata Storti Foundation (1)

More Publishers

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CSF1/CSF1R signaling inhibitor pexidartinib (PLX3397) reprograms tumor-associated macrophages and stimulates T-cell infiltration in the sarcoma microenvironment
    Journal Article

    Fujiwara, T.; Yakoub, M. A.; Chandler, A.; Christ, A. B.; Yang, G.; Ouerfelli, O.; Rajasekhar, V. K.; Yoshida, A.; Kondo, H.; Hata, T.; more...
    Molecular Cancer Therapeutics (2021)

    Fulltext@MSK | Save
  • Artesunate, an antimalarial drug displays preclinical activity in Flt3 mutated leukemia and synergises with arac
    Meeting Abstract

    Mony, U.; Hoya-Arias, R.; Ambati, S.; Pera, B.; Dogan, Y.; Peguero, E.; Shieh, J.H.; Moore, M.
    Haematologica (2014)

    Fulltext@MSK | Save
  • Multifaceted regulation of somatic cell reprogramming by mRNA translational control
    Journal Article

    Tahmasebi, S.; Alain, T.; Rajasekhar, V. K.; Zhang, J. P.; Prager-Khoutorsky, M.; Khoutorsky, A.; Dogan, Y.; Gkogkas, C. G.; Petroulakis, E.; Sylvestre, A.; more...
    Cell Stem Cell (2014)

    Fulltext@MSK | Save
  • Crizotinib, a c-Met Inhibitor, Prevents Metastasis in a Metastatic Uveal Melanoma Model
    Journal Article

    Surriga, O.; Rajasekhar, V. K.; Ambrosini, G.; Dogan, Y.; Huang, R.; Schwartz, G. K.
    Molecular Cancer Therapeutics (2013)

    Fulltext@MSK | Save
  • PLZF confers effector functions to donor T cells that preserve graft-versus-tumor effects while attenuating GVHD
    Journal Article

    Ghosh, A.; Holland, A. M.; Dogan, Y.; Yim, N. L.; Rao, U. K.; Young, L. F.; West, M. L.; Singer, N. V.; Lee, H.; Na, I. K.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity
    Journal Article

    Ghosh, A.; Dogan, Y.; Moroz, M.; Holland, A. M.; Yim, N. L.; Rao, U. K.; Young, L. F.; Tannenbaum, D.; Masih, D.; Velardi, E.; more...
    Journal of Clinical Investigation (2013)

    Fulltext@MSK | Save
  • Expression of ews-fli1 in human mesenchymal stem cells via lentiviral transduction reveals a characterisitic genetic signature
    Meeting Abstract

    Ambati, S.; Dogan, Y.; Ashbridge, B.; Chua, R.; Ladanyi, M.; Meyers, P.; Moore, M.
    Pediatric Blood and Cancer (2012)

    Fulltext@MSK | Save
  • Tunneling nanotubes provide a unique conduit for intercellular transfer of cellular contents in human malignant pleural mesothelioma
    Journal Article

    Lou, E.; Fujisawa, S.; Morozov, A.; Barlas, A.; Romin, Y.; Dogan, Y.; Gholami, S.; Moreira, A. L.; Manova-Todorova, K.; Moore, M. A. S.
    PLoS ONE (2012)

    Fulltext@MSK | Save
  • Trail over-expression on donor T cells enhances GVT and suppresses GVHD by inhibiting alloreactive T cells and impairing host APC functions
    Meeting Abstract

    Ghosh, A.; Dogan, Y.; Holland, A. M.; Young, L. F.; West, M. L.; Singer, N. V.; Smith, O. M.; Jenq, R. R.; Na, I. K.; Penack, O.; more...
    Biology of Blood and Marrow Transplantation (2012)

    Fulltext@MSK | Save
  • Genetically engineered allogeneic T Cells for BMT immunotherapy: Expression of TRAIL and PLZF selectively enhances GVT and abrogates GVHD
    Meeting Abstract

    Ghosh, A.; Holland, A. M.; Dogan, Y.; Yim, N.; Rao, U. K.; Young, L. F.; Smith, O. M.; Jenq, R.; Na, I. K.; Tsai, J. J.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save